Latest / Cleveland Clinic Cancer Advances
Innovations in Cancer Screening and Accuracy
A prototype blood-based screening test evaluated by Cleveland Clinic researchers and other experts can accurately identify the presence and originating site of 12 high-mortality cancer types, across all stages of progression, with a low false-positive rate, according to the latest results of an ongoing national clinical trial. Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute and the co-principal investigator of Cleveland Clinic’s portion of the study joins the Cancer Advances podcast to discuss this trial and the path forward to further validate this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.